Univariate and multivariate analyses indicate that Wnt3a is an independent prognostic factor in patients with LSCC and is a useful biomarker for assessing lymph node metastasis and prognosis in patients with LSCC. The gene discussed is WNT3A; the disease is metastatic malignant neoplasm in the lymph nodes.